KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Revenue (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Revenue for 6 consecutive years, with $455.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 33.02% year-over-year to $455.1 million, compared with a TTM value of $1.9 billion through Dec 2025, up 37.97%, and an annual FY2025 reading of $1.9 billion, up 37.97% over the prior year.
  • Revenue was $455.1 million for Q4 2025 at Clover Health Investments, down from $496.6 million in the prior quarter.
  • Across five years, Revenue topped out at $1.4 billion in Q3 2022 and bottomed at $9.3 million in Q4 2023.
  • Average Revenue over 5 years is $487.2 million, with a median of $456.0 million recorded in 2025.
  • The sharpest move saw Revenue tumbled 98.96% in 2023, then soared 3573.25% in 2024.
  • Year by year, Revenue stood at $655.5 million in 2021, then surged by 37.11% to $898.8 million in 2022, then crashed by 98.96% to $9.3 million in 2023, then skyrocketed by 3573.25% to $342.2 million in 2024, then surged by 33.02% to $455.1 million in 2025.
  • Business Quant data shows Revenue for CLOV at $455.1 million in Q4 2025, $496.6 million in Q3 2025, and $483.0 million in Q2 2025.